HIV-Specific Vaccine Therapy: Concepts, Status, and Future Directions
- 1 June 1992
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (6) , 1051-1058
- https://doi.org/10.1089/aid.1992.8.1051
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1Journal of Immunological Methods, 1992
- Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.Proceedings of the National Academy of Sciences, 1988
- HIV Infection: The Clinical PictureScientific American, 1988
- HIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected IndividualsScience, 1988
- Prospects for the control of AIDS by immunizing seropositive individualsNature, 1987
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Immunization against AIDS in humansNature, 1987
- The Walter Reed Staging Classification for HTLV-III/LAV InfectionNew England Journal of Medicine, 1986
- REPAIRING THE T-CELL DEFECT IN AIDSThe Lancet, 1985